Literature DB >> 7640329

Hormonal responses to the administration of m-chlorophenylpiperazine in patients with seasonal affective disorder and controls.

D Garcia-Borreguero1, F M Jacobsen, D L Murphy, J R Joseph-Vanderpool, A Chiara, N E Rosenthal.   

Abstract

We report on the plasma cortisol and prolactin responses to the serotonergic agonist m-CPP (0.1 mg/kg) in 10 patients with winter seasonal affective disorder (SAD) and 10 controls during the winter, in both untreated and bright light-treated conditions; and on 8 other SAD patients and 8 other controls during the summer. Following m-CPP infusion, untreated patients had exaggerated prolactin (p < .05) and cortisol (p < .05) responses compared to controls. Light treatment significantly reduced responses of both hormones to m-CPP (prolactin: p < .01; cortisol: p < .01). When untreated winter subjects and summer subjects were compared, cortisol, but not prolactin responses to m-CPP were found to be higher in patients than in controls during the winter, and lower in patients than in controls during the summer (diagnosis by season: p < .05). These results are consistent with those of our previous report on the behavioral responses to m-CPP in the same patients and suggest an abnormality in serotonergic function in untreated SAD patients in winter, which is normalized following treatment with light therapy and naturally during the summer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7640329     DOI: 10.1016/0006-3223(94)00208-K

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  4 in total

Review 1.  Pathophysiology of seasonal affective disorder: a review.

Authors:  R W Lam; R D Levitan
Journal:  J Psychiatry Neurosci       Date:  2000-11       Impact factor: 6.186

2.  Seasonality of cerebrospinal fluid monoamine metabolite concentrations and their associations with meteorological variables in humans.

Authors:  Timothy D Brewerton; Karen T Putnam; Richard R J Lewine; S Craig Risch
Journal:  J Psychiatr Res       Date:  2018-01-12       Impact factor: 4.791

3.  Short exposure to light treatment improves depression scores in patients with seasonal affective disorder: A brief report.

Authors:  Gagan Virk; Gloria Reeves; Norman E Rosenthal; Leo Sher; Teodor T Postolache
Journal:  Int J Disabil Hum Dev       Date:  2009-07

4.  A placebo-controlled study of sertraline in the treatment of outpatients with seasonal affective disorder.

Authors:  Adam Moscovitch; Carl A Blashko; John M Eagles; Guy Darcourt; Christopher Thompson; Siegfried Kasper; Roger M Lane
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.